APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lysine Specific Demethylase 1 Inhibitor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lysine Specific Demethylase 1 Inhibitor Market Analysis and Forecast 2026-2032

30 December 2025190 pages

Choose your research edition.

Industry ResearchLysine Specific Demethylase 1 Inhibitor Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Lysine Specific Demethylase 1 Inhibitor Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Lysine Specific Demethylase 1 Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lysine Specific Demethylase 1 Inhibitor Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Lysine Specific Demethylase 1 Inhibitor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lysine Specific Demethylase 1 Inhibitor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lysine Specific Demethylase 1 Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lysine Specific Demethylase 1 Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lysine Specific Demethylase 1 Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lysine Specific Demethylase 1 Inhibitor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lysine Specific Demethylase 1 Inhibitor include 4SC, Beatica, Celgene Corporation, CSPC ZhongQi Pharmaceutical Technology, Oryzon Genomics, Rasna Therapeutic, Salarius Pharmaceuticals and Taiho Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lysine Specific Demethylase 1 Inhibitor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lysine Specific Demethylase 1 Inhibitor, also provides the sales of main regions and countries. Of the upcoming market potential for Lysine Specific Demethylase 1 Inhibitor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lysine Specific Demethylase 1 Inhibitor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lysine Specific Demethylase 1 Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lysine Specific Demethylase 1 Inhibitor sales, projected growth trends, production technology, application and end-user industry.

Lysine Specific Demethylase 1 Inhibitor Segment by Company

4SC

Beatica

Celgene Corporation

CSPC ZhongQi Pharmaceutical Technology

Oryzon Genomics

Rasna Therapeutic

Salarius Pharmaceuticals

Taiho Pharmaceutical

Lysine Specific Demethylase 1 Inhibitor Segment by Type

Vaccine

Monoclonal Antibody

Lysine Specific Demethylase 1 Inhibitor Segment by Application

Breast Cancer

Prostate Cancer

Others

Lysine Specific Demethylase 1 Inhibitor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysine Specific Demethylase 1 Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lysine Specific Demethylase 1 Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysine Specific Demethylase 1 Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lysine Specific Demethylase 1 Inhibitor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lysine Specific Demethylase 1 Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lysine Specific Demethylase 1 Inhibitor sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lysine Specific Demethylase 1 Inhibitor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vaccine Major Manufacturers Table 3. Monoclonal Antibody Major Manufacturers Table 4. Global Lysine Specific Demethylase 1 Inhibitor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Breast Cancer Major Manufacturers Table 6. Prostate Cancer Major Manufacturers Table 7. Others Major Manufacturers Table 8. Lysine Specific Demethylase 1 Inhibitor Industry Trends Table 9. Lysine Specific Demethylase 1 Inhibitor Industry Drivers Table 10. Lysine Specific Demethylase 1 Inhibitor Industry Opportunities and Challenges Table 11. Lysine Specific Demethylase 1 Inhibitor Industry Restraints Table 12. Global Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2021-2026) Table 16. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2027-2032) Table 17. Global Lysine Specific Demethylase 1 Inhibitor Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2021-2026) & (K Units) Table 19. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2027-2032) & (K Units) Table 20. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2021-2026) Table 21. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2027-2032) Table 22. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Lysine Specific Demethylase 1 Inhibitor Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Manufacturers (2021-2026) Table 26. Global Lysine Specific Demethylase 1 Inhibitor Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Lysine Specific Demethylase 1 Inhibitor Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Lysine Specific Demethylase 1 Inhibitor Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Lysine Specific Demethylase 1 Inhibitor Manufacturers, Product Type & Application Table 30. Global Lysine Specific Demethylase 1 Inhibitor Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Lysine Specific Demethylase 1 Inhibitor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2021-2026) Table 37. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2027-2032) Table 38. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2026) & (K Units) Table 40. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2027-2032) & (K Units) Table 41. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2021-2026) Table 42. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2027-2032) Table 43. Global Lysine Specific Demethylase 1 Inhibitor Price by Type (2021-2026) & (US$/Unit) Table 44. Global Lysine Specific Demethylase 1 Inhibitor Price by Type (2027-2032) & (US$/Unit) Table 45. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2021-2026) Table 49. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2027-2032) Table 50. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2026) & (K Units) Table 52. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2027-2032) & (K Units) Table 53. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2021-2026) Table 54. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2027-2032) Table 55. Global Lysine Specific Demethylase 1 Inhibitor Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lysine Specific Demethylase 1 Inhibitor Price by Application (2027-2032) & (US$/Unit) Table 57. 4SC Company Information Table 58. 4SC Business Overview Table 59. 4SC Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. 4SC Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 61. 4SC Recent Development Table 62. Beatica Company Information Table 63. Beatica Business Overview Table 64. Beatica Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Beatica Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 66. Beatica Recent Development Table 67. Celgene Corporation Company Information Table 68. Celgene Corporation Business Overview Table 69. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 71. Celgene Corporation Recent Development Table 72. CSPC ZhongQi Pharmaceutical Technology Company Information Table 73. CSPC ZhongQi Pharmaceutical Technology Business Overview Table 74. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 76. CSPC ZhongQi Pharmaceutical Technology Recent Development Table 77. Oryzon Genomics Company Information Table 78. Oryzon Genomics Business Overview Table 79. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 81. Oryzon Genomics Recent Development Table 82. Rasna Therapeutic Company Information Table 83. Rasna Therapeutic Business Overview Table 84. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 86. Rasna Therapeutic Recent Development Table 87. Salarius Pharmaceuticals Company Information Table 88. Salarius Pharmaceuticals Business Overview Table 89. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 91. Salarius Pharmaceuticals Recent Development Table 92. Taiho Pharmaceutical Company Information Table 93. Taiho Pharmaceutical Business Overview Table 94. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product Portfolio Table 96. Taiho Pharmaceutical Recent Development Table 97. North America Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2026) & (K Units) Table 100. North America Lysine Specific Demethylase 1 Inhibitor Sales by Type (2027-2032) & (K Units) Table 101. North America Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2026) & (K Units) Table 106. North America Lysine Specific Demethylase 1 Inhibitor Sales by Application (2027-2032) & (K Units) Table 107. North America Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 114. North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 115. North America Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 118. Canada Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 119. Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2026) & (K Units) Table 122. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Type (2027-2032) & (K Units) Table 123. Europe Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 124. Europe Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 125. Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2026) & (K Units) Table 128. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Application (2027-2032) & (K Units) Table 129. Europe Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 130. Europe Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 135. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 136. Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 137. Europe Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 138. Europe Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 139. Germany Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 140. France Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 141. U.K. Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 142. Italy Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 144. China Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 145. China Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 146. China Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2026) & (K Units) Table 147. China Lysine Specific Demethylase 1 Inhibitor Sales by Type (2027-2032) & (K Units) Table 148. China Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 149. China Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 150. China Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 151. China Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 152. China Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2026) & (K Units) Table 153. China Lysine Specific Demethylase 1 Inhibitor Sales by Application (2027-2032) & (K Units) Table 154. China Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 155. China Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2026) & (K Units) Table 159. Asia Lysine Specific Demethylase 1 Inhibitor Sales by Type (2027-2032) & (K Units) Table 160. Asia Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 161. Asia Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 162. Asia Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2026) & (K Units) Table 165. Asia Lysine Specific Demethylase 1 Inhibitor Sales by Application (2027-2032) & (K Units) Table 166. Asia Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 167. Asia Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. Asia Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 173. Asia Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 174. Asia Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 175. Asia Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Japan Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 177. South Korea Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 178. India Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 179. Australia Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 180. China Taiwan Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2026) & (K Units) Table 185. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Type (2027-2032) & (K Units) Table 186. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2021-2026) & (US$/Unit) Table 187. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Price by Type (2027-2032) & (US$/Unit) Table 188. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2026) & (K Units) Table 191. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Application (2027-2032) & (K Units) Table 192. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2021-2026) & (US$/Unit) Table 193. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Price by Application (2027-2032) & (US$/Unit) Table 194. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021-2026) & (K Units) Table 199. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Country (2027-2032) & (K Units) Table 200. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2021-2026) & (US$/Unit) Table 201. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Brazil Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 203. Argentina Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 204. Chile Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 205. Colombia Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 206. Peru Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 208. Israel Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 209. UAE Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 210. Turkey Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 211. Iran Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 212. Egypt Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Lysine Specific Demethylase 1 Inhibitor Distributors List Table 216. Lysine Specific Demethylase 1 Inhibitor Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Lysine Specific Demethylase 1 Inhibitor Image Figure 2. Global Lysine Specific Demethylase 1 Inhibitor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lysine Specific Demethylase 1 Inhibitor Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vaccine Image Figure 5. Monoclonal Antibody Image Figure 6. Global Lysine Specific Demethylase 1 Inhibitor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lysine Specific Demethylase 1 Inhibitor Market Size Share 2021 VS 2025 VS 2032 Figure 8. Breast Cancer Image Figure 9. Prostate Cancer Image Figure 10. Others Image Figure 11. Global Lysine Specific Demethylase 1 Inhibitor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lysine Specific Demethylase 1 Inhibitor Revenue (2021-2032) & (US$ Million) Figure 13. Global Lysine Specific Demethylase 1 Inhibitor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2021-2032) Figure 16. Global Lysine Specific Demethylase 1 Inhibitor Sales (2021-2032) & (K Units) Figure 17. Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Lysine Specific Demethylase 1 Inhibitor Sales YoY (2021-2032) & (K Units) Figure 20. Europe Lysine Specific Demethylase 1 Inhibitor Sales YoY (2021-2032) & (K Units) Figure 21. China Lysine Specific Demethylase 1 Inhibitor Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Lysine Specific Demethylase 1 Inhibitor Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Lysine Specific Demethylase 1 Inhibitor Sales YoY (2021-2032) & (K Units) Figure 24. Global Lysine Specific Demethylase 1 Inhibitor Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Lysine Specific Demethylase 1 Inhibitor Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2021-2032) Figure 30. Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2021-2032) Figure 33. Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2021-2032) Figure 36. Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2021-2032) Figure 39. North America Lysine Specific Demethylase 1 Inhibitor Revenue Share by Type (2021-2032) Figure 40. North America Lysine Specific Demethylase 1 Inhibitor Sales Share by Type (2021-2032) Figure 41. North America Lysine Specific Demethylase 1 Inhibitor Revenue Share by Application (2021-2032) Figure 42. North America Lysine Specific Demethylase 1 Inhibitor Sales Share by Application (2021-2032) Figure 43. North America Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country (2021-2032) Figure 44. North America Lysine Specific Demethylase 1 Inhibitor Sales Share by Country (2021-2032) Figure 45. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Share by Type (2021-2032) Figure 46. Europe Lysine Specific Demethylase 1 Inhibitor Sales Share by Type (2021-2032) Figure 47. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Share by Application (2021-2032) Figure 48. Europe Lysine Specific Demethylase 1 Inhibitor Sales Share by Application (2021-2032) Figure 49. Europe Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country (2021-2032) Figure 50. Europe Lysine Specific Demethylase 1 Inhibitor Sales Share by Country (2021-2032) Figure 51. China Lysine Specific Demethylase 1 Inhibitor Revenue Share by Type (2021-2032) Figure 52. China Lysine Specific Demethylase 1 Inhibitor Sales Share by Type (2021-2032) Figure 53. China Lysine Specific Demethylase 1 Inhibitor Revenue Share by Application (2021-2032) Figure 54. China Lysine Specific Demethylase 1 Inhibitor Sales Share by Application (2021-2032) Figure 55. Asia Lysine Specific Demethylase 1 Inhibitor Revenue Share by Type (2021-2032) Figure 56. Asia Lysine Specific Demethylase 1 Inhibitor Sales Share by Type (2021-2032) Figure 57. Asia Lysine Specific Demethylase 1 Inhibitor Revenue Share by Application (2021-2032) Figure 58. Asia Lysine Specific Demethylase 1 Inhibitor Sales Share by Application (2021-2032) Figure 59. Asia Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country (2021-2032) Figure 60. Asia Lysine Specific Demethylase 1 Inhibitor Sales Share by Country (2021-2032) Figure 61. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue Share by Type (2021-2032) Figure 62. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Share by Type (2021-2032) Figure 63. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue Share by Application (2021-2032) Figure 64. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Share by Application (2021-2032) Figure 65. SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue Share by Country (2021-2032) Figure 66. SAMEA Lysine Specific Demethylase 1 Inhibitor Sales Share by Country (2021-2032) Figure 67. Lysine Specific Demethylase 1 Inhibitor Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Lysine Specific Demethylase 1 Inhibitor Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Monoclonal Antibody
Applications
  • Breast Cancer
  • Prostate Cancer
  • Others
Companies covered
  • 4SC
  • Beatica
  • Celgene Corporation
  • CSPC ZhongQi Pharmaceutical Technology
  • Oryzon Genomics
  • Rasna Therapeutic
  • Salarius Pharmaceuticals
  • Taiho Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lysine Specific Demethylase 1 Inhibitor Market by Type
  3. 1.2.1 Global Lysine Specific Demethylase 1 Inhibitor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vaccine
  5. 1.2.3 Monoclonal Antibody
  6. 1.3 Lysine Specific Demethylase 1 Inhibitor Market by Application
  7. 1.3.1 Global Lysine Specific Demethylase 1 Inhibitor Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Breast Cancer
  9. 1.3.3 Prostate Cancer
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lysine Specific Demethylase 1 Inhibitor Market Dynamics
  1. 2.1 Lysine Specific Demethylase 1 Inhibitor Industry Trends
  2. 2.2 Lysine Specific Demethylase 1 Inhibitor Industry Drivers
  3. 2.3 Lysine Specific Demethylase 1 Inhibitor Industry Opportunities and Challenges
  4. 2.4 Lysine Specific Demethylase 1 Inhibitor Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region
  3. 3.2.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2021-2026)
  5. 3.2.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Region (2027-2032)
  6. 3.2.4 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region
  9. 3.4.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2021-2026)
  11. 3.4.3 Global Lysine Specific Demethylase 1 Inhibitor Sales by Region (2027-2032)
  12. 3.4.4 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Manufacturers
  2. 4.1.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lysine Specific Demethylase 1 Inhibitor Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Manufacturers
  6. 4.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lysine Specific Demethylase 1 Inhibitor Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lysine Specific Demethylase 1 Inhibitor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lysine Specific Demethylase 1 Inhibitor Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lysine Specific Demethylase 1 Inhibitor Manufacturers, Product Type & Application
  13. 4.7 Global Lysine Specific Demethylase 1 Inhibitor Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lysine Specific Demethylase 1 Inhibitor Market CR5 and HHI
  16. 4.8.2 2025 Lysine Specific Demethylase 1 Inhibitor Tier 1, Tier 2, and Tier 3
5 Lysine Specific Demethylase 1 Inhibitor Market by Type
  1. 5.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type
  2. 5.1.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type
  6. 5.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lysine Specific Demethylase 1 Inhibitor Price by Type
6 Lysine Specific Demethylase 1 Inhibitor Market by Application
  1. 6.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application
  2. 6.1.1 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lysine Specific Demethylase 1 Inhibitor Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application
  6. 6.2.1 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lysine Specific Demethylase 1 Inhibitor Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lysine Specific Demethylase 1 Inhibitor Price by Application
7 Company Profiles
  1. 7.1 4SC
  2. 7.1.1 4SC Company Information
  3. 7.1.2 4SC Business Overview
  4. 7.1.3 4SC Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 4SC Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  6. 7.1.5 4SC Recent Developments
  7. 7.2 Beatica
  8. 7.2.1 Beatica Company Information
  9. 7.2.2 Beatica Business Overview
  10. 7.2.3 Beatica Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beatica Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  12. 7.2.5 Beatica Recent Developments
  13. 7.3 Celgene Corporation
  14. 7.3.1 Celgene Corporation Company Information
  15. 7.3.2 Celgene Corporation Business Overview
  16. 7.3.3 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Celgene Corporation Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  18. 7.3.5 Celgene Corporation Recent Developments
  19. 7.4 CSPC ZhongQi Pharmaceutical Technology
  20. 7.4.1 CSPC ZhongQi Pharmaceutical Technology Company Information
  21. 7.4.2 CSPC ZhongQi Pharmaceutical Technology Business Overview
  22. 7.4.3 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CSPC ZhongQi Pharmaceutical Technology Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  24. 7.4.5 CSPC ZhongQi Pharmaceutical Technology Recent Developments
  25. 7.5 Oryzon Genomics
  26. 7.5.1 Oryzon Genomics Company Information
  27. 7.5.2 Oryzon Genomics Business Overview
  28. 7.5.3 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Oryzon Genomics Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  30. 7.5.5 Oryzon Genomics Recent Developments
  31. 7.6 Rasna Therapeutic
  32. 7.6.1 Rasna Therapeutic Company Information
  33. 7.6.2 Rasna Therapeutic Business Overview
  34. 7.6.3 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Rasna Therapeutic Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  36. 7.6.5 Rasna Therapeutic Recent Developments
  37. 7.7 Salarius Pharmaceuticals
  38. 7.7.1 Salarius Pharmaceuticals Company Information
  39. 7.7.2 Salarius Pharmaceuticals Business Overview
  40. 7.7.3 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Salarius Pharmaceuticals Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  42. 7.7.5 Salarius Pharmaceuticals Recent Developments
  43. 7.8 Taiho Pharmaceutical
  44. 7.8.1 Taiho Pharmaceutical Company Information
  45. 7.8.2 Taiho Pharmaceutical Business Overview
  46. 7.8.3 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Taiho Pharmaceutical Lysine Specific Demethylase 1 Inhibitor Product Portfolio
  48. 7.8.5 Taiho Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Lysine Specific Demethylase 1 Inhibitor Market Size by Type
  2. 8.1.1 North America Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2032)
  3. 8.1.2 North America Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2032)
  4. 8.1.3 North America Lysine Specific Demethylase 1 Inhibitor Price by Type (2021-2032)
  5. 8.2 North America Lysine Specific Demethylase 1 Inhibitor Market Size by Application
  6. 8.2.1 North America Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2032)
  7. 8.2.2 North America Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2032)
  8. 8.2.3 North America Lysine Specific Demethylase 1 Inhibitor Price by Application (2021-2032)
  9. 8.3 North America Lysine Specific Demethylase 1 Inhibitor Market Size by Country
  10. 8.3.1 North America Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lysine Specific Demethylase 1 Inhibitor Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Lysine Specific Demethylase 1 Inhibitor Market Size by Type
  2. 9.1.1 Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2032)
  4. 9.1.3 Europe Lysine Specific Demethylase 1 Inhibitor Price by Type (2021-2032)
  5. 9.2 Europe Lysine Specific Demethylase 1 Inhibitor Market Size by Application
  6. 9.2.1 Europe Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2032)
  8. 9.2.3 Europe Lysine Specific Demethylase 1 Inhibitor Price by Application (2021-2032)
  9. 9.3 Europe Lysine Specific Demethylase 1 Inhibitor Market Size by Country
  10. 9.3.1 Europe Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lysine Specific Demethylase 1 Inhibitor Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Lysine Specific Demethylase 1 Inhibitor Market Size by Type
  2. 10.1.1 China Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2032)
  3. 10.1.2 China Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2032)
  4. 10.1.3 China Lysine Specific Demethylase 1 Inhibitor Price by Type (2021-2032)
  5. 10.2 China Lysine Specific Demethylase 1 Inhibitor Market Size by Application
  6. 10.2.1 China Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2032)
  7. 10.2.2 China Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2032)
  8. 10.2.3 China Lysine Specific Demethylase 1 Inhibitor Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lysine Specific Demethylase 1 Inhibitor Market Size by Type
  2. 11.1.1 Asia Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2032)
  4. 11.1.3 Asia Lysine Specific Demethylase 1 Inhibitor Price by Type (2021-2032)
  5. 11.2 Asia Lysine Specific Demethylase 1 Inhibitor Market Size by Application
  6. 11.2.1 Asia Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2032)
  8. 11.2.3 Asia Lysine Specific Demethylase 1 Inhibitor Price by Application (2021-2032)
  9. 11.3 Asia Lysine Specific Demethylase 1 Inhibitor Market Size by Country
  10. 11.3.1 Asia Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lysine Specific Demethylase 1 Inhibitor Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lysine Specific Demethylase 1 Inhibitor Market Size by Type
  2. 12.1.1 SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lysine Specific Demethylase 1 Inhibitor Price by Type (2021-2032)
  5. 12.2 SAMEA Lysine Specific Demethylase 1 Inhibitor Market Size by Application
  6. 12.2.1 SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lysine Specific Demethylase 1 Inhibitor Price by Application (2021-2032)
  9. 12.3 SAMEA Lysine Specific Demethylase 1 Inhibitor Market Size by Country
  10. 12.3.1 SAMEA Lysine Specific Demethylase 1 Inhibitor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lysine Specific Demethylase 1 Inhibitor Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lysine Specific Demethylase 1 Inhibitor Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lysine Specific Demethylase 1 Inhibitor Value Chain Analysis
  2. 13.1.1 Lysine Specific Demethylase 1 Inhibitor Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lysine Specific Demethylase 1 Inhibitor Production Mode & Process
  6. 13.2 Lysine Specific Demethylase 1 Inhibitor Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lysine Specific Demethylase 1 Inhibitor Distributors
  9. 13.2.3 Lysine Specific Demethylase 1 Inhibitor Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst